Top

Veniti inks distro deal with Boston Scientific for Vici venous stent

September 11, 2017

Veniti said today it inked a limited global distribution deal with Boston Scientific (NYSE:BSX) for its Vici venous stent.

The companies did not release details on which regions Boston Scientific would distribute the stent in or any financial terms of the deal.

“The Vici venous stent is widely recognized as state-of-the-art technology for venous stents and physicians routinely praise the product for its performance qualities. We are extremely pleased to be partnering with a global industry leader like Boston Scientific to advance the Vici Venous Stent in the marketplace.

Read More on Mass Device